Stahl’s Illustrated Guides
www.cambridge.org/stahl
Titles in the Stahl’s Illustrated Series are designed to be fun. Concepts are illustrated by full-colour images that will be familiar to all readers of Stahl’s Essential Psychopharmacology (3rd Ed.) and The Prescriber’s Guide. The visual learner will find that these books make psychopharmacology concepts easy to master, while the non-visual learner will enjoy a shortened text version of complex psychopharmacology concepts. Within each book, each chapter builds on previous chapters, synthesizing information from basic biology and diagnostics to building treatment plans and dealing with complications and comorbidities. Novices may want to approach Stahl’s Illustrated Series by first looking through all the graphics and gaining a feel for the visual vocabulary. Readers more familiar with these topics should find that going back and forth between images and text provides an interaction with which to vividly conceptualise complex pharmacologies.
Chronic Pain and Fibromyalgia Stahl, Stephen M. Contents: 1. Pain affects us all; 2. Neurobiology of pain; 3. The ‘pain patient’; 4. Pain disorders; 5. Pain drugs; 6. Monitoring and caring for patients in pain. November 2009 176 pages 144 b/w illus. 7 tables 9780521133227 Paperback £27.99
Mood Stabilizers Stahl, Stephen M. Contents: 1. Symptoms and spectrum of bipolar disorder; 2. From symptoms to circuits; 3. From circuits to mechanisms; 4. Lithium and various anticonvulsants as mood stabilizers for bipolar disorder; 5. Atypical antipsychotics as mood stabilizers for bipolar disorder; 6. Building a treatment plan. June 2009 176 pages 150 colour illus. 10 tables 9780521758499 Paperback £27.99
Attention Deficit Hyperactivity Disorder Stahl, Stephen M. and Mignon, Laurence Contents: 1. Neurobiology, circuits, genetics; 2. ADHD across the ages; 3. Comorbidities of ADHD; 4. Drugs and mechanism of actions. November 2009 166 pages 100 b/w illus. 9 tables 9780521133159 Paperback £27.99
Antipsychotics Treating Psychosis, Mania and Depression 2nd Ed Stahl, Stephen M. and Mignon, Laurence Contents: 1. Neurobiology of schizophrenia and mood disorders; 2. Multifunctionality of antipsychotics; 3. Side effects of antipsychotics: metabolic issues and sedation; 4. Individual antipsychotic drugs; 5. Schizophrenia pharmacy and switching strategies. June 2010 200 pages 178 b/w illus. 7 tables 9780521149051 Paperback £27.99
Antidepressants Stahl, Stephen M.
Contents: 1. Neurobiology of depression; 2. Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs); 3. Norepinephrine and dopamine reuptake inhibitors (NDRIs) and selective norepinephrine reuptake inhibitors (NRIs); 4. Alpha 2 antagonists as serotonin and norepinephrine; 5. Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs); 6. Building a treatment plan with novel treatment and augmentation options for depression; 7. Depression in women: treating symptoms throughout the life span; 8. Pharmacokinetics and algorithms to treat depression. May 2009 200 pages 219 colour illus. 9 tables 9780521758529 Paperback £27.99
Anxiety, Stress, and PTSD Stahl, Stephen M. and Grady, Meghan M. Contents: 1. Neurobiology of stress and anxiety; 2. Post-traumatic stress disorder (PTSD); 3. Neurotransmitter systems as pharmacological targets for PTSD; 4. First-line medications for PTSD; 5. Second-line, adjunct, and investigational medications for PTSD; 6. Cognitive behavioral therapy (CBT) for PTSD; 7. Caring for patients with PTSD; 8. Unique considerations for the military population; Summary. July 2010 200 pages 143 b/w illus. 11 tables 27 exercises 9780521153997 Paperback £27.99
Next Generation Antidepressants
COMING SOON
Essential CNS Drug Development Amir Kalali, Joseph Kwentus, Sheldon Preskorn, and Stephen M. Stahl Contents: Preface; 1. History of CNS drug development Sheldon H. Preskorn; 2. Regulatory issues Gwen L. Zornberg; 3. Pre-clinical development Alan J. Cross and Frank D. Yocca; 4. Phase I trials: from traditional to newer approaches Matthew Macaluso, Michael Krams and Sheldon H. Preskorn; 5. Phase II development and the path to personalized medicine in CNS disease Douglas E. Feltner and Kenneth R. Evans; 6. CNS drug development – Phase III Judith Dunn, Penny Randall and Amir Kalali; 7. Statistics issues relevant to CNS drug development Craig H. Mallinckrodt, William R. Prucka and Geert Molenberghs; 8. Clinical trials management at company level Nuala Murphy; 9. Clinical trials management at the site level Joseph Kwentus; 10. Medical writing for CNS indications Ginette Nachman; 11. Dissemination of clinical trial information: multiple audiences, multiple formats Leslie Citrome; 12. The importance of treating cognition in schizophrenia and other severe mental illnesses: background, strategies, and findings to date Philip D. Harvey and Richard S. E. Keefe; 13. Leveraging disruptive technologies to drive innovation in CNS clinical drug development Penny Randall, Judith Dunn and Amir Kalali; Index. Available from April 2012 232 pages 27 b/w illus. 23 tables 9780521766067 Hardback c. £65.00
COMING SOON Stahl’s
Self-Assessment Examination in Psychiatry Multiple Choice Questions for Clinicians Stahl, Stephen M. Practitioners, students, and teachers use Stahl’s books and websites to prepare for formal tests, including Board examinations and to achieve CME credits and MoC (Maintenance of Certification) credits towards ongoing ABPN re-accreditation. This book presents a set of self-assessment questions derived from Dr Stahl’s Online Master Psychopharmacology Program. The questions themselves are learning exercises as each one is followed by a thorough explanation of the correct and incorrect answer choices. There are approximately 150 questions divided into ten core areas of psychiatry. This title is ideal for anyone seeking a revision tool in psychopharmacology, either for exam, re-accreditation or self-guided learning purposes. It will also allow those from outside the field of psychiatry to determine whether their competence is equivalent to those taking more formal tests. April 2012 9781107681590 Paperback
£28.99
Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders Edited by Beyer, Chad E. and Stahl, Stephen M. Contents: Preface Chad E. Beyer; 1. Current depression landscape: a state of the field today Laurence Mignon and Stephen M. Stahl; 2. Novel therapeutic targets for treating affective disorders Eliyahu Dremencov and Thomas Cremers; 3. Developing novel animal models of depression Lotte de Groote, Malgorzata Filip and Andrew C. McCreary; 4. Translational research in mood disorders: using imaging technologies in biomarker research Jul Lea Shamy, Adam M. Brickman, Chris D. Griesemer, Anna Parachikova and Mark Day; 5. Defining depression endophenotypes Lisa H. Berghorst and Diego A. Pizzagalli; 6. Genetic and genomic studies of major depressive disorder Roy H. Perlis; 7. Medicinal chemistry challenges in the design of next generation antidepressants David P. Rotella; 8. Application of pharmacogenomics and personalized medicine for the care of depression Keh-Ming Lin, Chun-Yu Chen and Yu-Jui Yvonne Wan; Index. 20 May 2010 150 pages 27 b/w illus. 10 tables 9780521760584 Hardback £55.00
COMING SOON Essential
Evidence-Based Psychopharmacology 2nd Edition Edited by Stein, D., Lerer, B. and Stahl, S.M. This 2nd Edition presents up-to-date, comprehensive and high quality reviews of the psychopharmacological evidence-base for each of the major psychiatric disorders, written by expert psychopharmacologists from around the world. It summarises the wealth of new developments in the field and sets them within the context of day-to-day clinical practice. All chapters have been fully updated and new contributions on personality disorders and substance dependence added. Available from March 2012 336 pages 3 b/w illus 9781107007956 Hardback c. £90.00 9781107400108 Paperback c. £45.00